beta-escin has been researched along with 20-hydroxy-5-8-11-14-eicosatetraenoic-acid* in 1 studies
1 other study(ies) available for beta-escin and 20-hydroxy-5-8-11-14-eicosatetraenoic-acid
Article | Year |
---|---|
Effects of omega-hydroxylase product on distal human pulmonary arteries.
The aim of the present study was to provide a mechanistic insight into how 20-hydroxyeicosatetraenoic acid (20-HETE) relaxes distal human pulmonary arteries (HPAs). This compound is produced by omega-hydroxylase from free arachidonic acid. Tension measurements, performed on either fresh or 1 day-cultured pulmonary arteries, revealed that the contractile responses to 1 microM 5-hydroxytryptamine were largely relaxed by 20-HETE in a concentration-dependent manner (0.01-10 microM). Iberiotoxin pretreatments (10 nM) partially decreased 20-HETE-induced relaxations. However, 10 microM indomethacin and 3 microM SC-560 pretreatments significantly reduced the relaxations to 20-HETE in these tissues. The relaxing responses induced by the eicosanoid were likely related to a reduced Ca2+ sensitivity of the myofilaments since free Ca2+ concentration ([Ca2+])-response curves performed on beta-escin-permeabilized cultured explants were shifted toward higher [Ca2+]. 20-HETE also abolished the tonic responses induced by phorbol-ester-dibutyrate (a PKC-sensitizing agent). Western blot analyses, using two specific primary antibodies against the PKC-potentiated inhibitory protein CPI-17 and its PKC-dependent phosphorylated isoform pCPI-17, confirmed that 20-HETE interferes with this intracellular process. We also investigated the effect of 20-HETE on the activation of Rho-kinase pathway-induced Ca2+ sensitivity. The data demonstrated that 20-HETE decreased U-46619-induced Ca2+ sensitivity on arteries. Hence, this observation was correlated with an increased staining of p116(Rip), a RhoA-binding protein. Together, these results strongly suggest that the 20-hydroxyarachidonic acid derivative is a potent modulator of tone in HPAs in vitro. Topics: Adaptor Proteins, Signal Transducing; Blotting, Western; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP4A; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Escin; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Isometric Contraction; Muscle Proteins; Muscle Relaxation; Muscle, Smooth, Vascular; Peptides; Phosphoprotein Phosphatases; Potassium Channels, Calcium-Activated; Protein Kinase C; Pulmonary Artery; Vascular Resistance | 2008 |